Возможные пути реализации повторной радиотерапии при рецидивах высокозлокачественных (WHO Grade ІІІ-ІV) глиом головного мозга (краткий обзор литературы)

Автор: Паньшин Г.А.

Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr

Статья в выпуске: 1 т.18, 2018 года.

Бесплатный доступ

Встатье анализируется современное состояние вопроса о показаниях к проведению повторного конформного облучения рецидивов высокозлокачественных глиом головного мозга с учетом развития возможных реакций и повреждений со стороны тканей головного мозга после его реализации, путей их профилактики и методического обеспечения процесса радиотерапии.

Рецидивы высокозлокачественных глиом головного мозга, повторное облучение, профилактика постлучевых некрозов головного мозга, методики радиотерапии

Короткий адрес: https://sciup.org/14955566

IDR: 14955566

Список литературы Возможные пути реализации повторной радиотерапии при рецидивах высокозлокачественных (WHO Grade ІІІ-ІV) глиом головного мозга (краткий обзор литературы)

Балканов А.С., Степанова Е.А., Сташук Г.А. Способ выбора тактики лечения рецидива злокачественной глиомы головного мозга. Патент РФ 2470586. Дата публикации:27.12.2012.
Каныгин В.В., Кичигин А.И., Губанова Н.В., Таскаев С.Ю. Возможности бор-нейтронозахватной терапии в лечении злокачественных опухолей головного мозга. Вестник рентгенологии и радиологии. 2015. № 6. C. 36-42.
Гаганов Л.Е., Балканов А.С. Способ определения возможности проведения повторной дисианционной гамма-терапии при рецидиве злокачественной глиомы головнго мозга. Патент №2269126. Дата публикации: 27.01.2006.
Aihara T., Hiratsuka J., Morita N., et al. First clinical case of boron neutron capture therapy for head and neck malignancies using 18 F-BPA PET. Head Neck. 2006. V. 28. No.9. P. 850-855.
Albritton J.R., Kiger III, W.S. Neutron beam source definition techniques for NCT treatment planning. In: Zonta A. (Ed.); Proceedings of 13th ICNCT. ENEA, Rome. 2008. P. 571-574.
Alexiou G.A., Tsiouris S., Kyritsis A.P., et al. Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities. J Neorooncol. 2009. V. 95. No. 1. P. 1-11.
Ammirati M., Galicich J.H., Arbit E., Liao Y. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery. 1987. V. 21. No. 5. P. 607-614.
Bederson J., Harsh G., Walker J., et al. Radiation-induced bilateral cystic temporal lobe necrosis: reversal of memory deficit after fenestration and internal shunting. Case report. J Neurosurg. 1990. V. 72. No. 3. P. 503-505.
Brandsma D., van den Bent M.J. Pseudoprogression and pseudoresponse in the treatment of gliomas.Curr Opin Neurol. 2009. V. 22. No. 6. P. 633-638.
Bregadze V.I., Sivaev I.B. Polyhedral boron compounds for BNCT. In Boron Science: New Technologies and Applications. Hosmane N.S. (Ed.); CRC Press. 2011. P. 181-207.
Brock M., Cervos-Navarro J., Holdorff B. Changes in intracranial pressure associated with delayed cerebral radionecrosis. Surg Neurol. 1984. V. 22. No. 1. P. 8-16.
Buatti J., Friedman W., Theele D., et al. The lazaroid U74389G protects normal brain from stereotactic radiosurgery-induced radiation injury. Int J Radiat Oncol Biol Phys. 1996. V. 34. No. 3. P. 591-597.
Capala J., Barth R.F., Bendayan M., et al. Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors. Bioconjug Chem. 1996. V. 7. No. 1. P. 7-15.
Chen Y., Trotti A., Coleman C., et al. Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation. Int J Radiat Oncol Biol Phys. 2006. V. 64. No. 5. P. 1442-1451.
Cheng K., Chan C., Fu Y., et al. Brain abscess formation in radiation necrosis of the temporal lobe following radiation therapy for nasopharyngeal carcinoma. Acta Neurochir (Wien). 2000. V. 142. No. 4. P. 435-431.
Combs S.E., Thilmann C., Edler L., et al. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: Long-term results in 172 patients treated in a single institution. J Clin Oncol. 2005. V. 23. No. 34. P. 8863-8869.
Combs S., Bischof M., Welzel T. Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas. J Neurooncol. 2008. V. 89. No. 2. P. 205-210.
Conti A., Pontoriero A., Arpa D., et al. Efficacy and toxicity of CyberKnife re-irradiation and ‘dose dense’ temozolomide for recurrent gliomas. Acta Neurochir (Wien). 2012. V. 154. No. 2. P. 203-209.
Cuneo K.C., Vredenburgh J.J., Sampson J.H., et al. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2012. V. 82. No. 5. P. 2018-2024.
Derlon J., Bourdet C., Bustany P., et al. -methionine uptake in gliomas. Neurosurgery. 1989. V. 25. No. 5. P. 720-728.
Fogh S.E., Andrews D.W., Glass J., et al. Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol. 2010. V. 28. No. 18. P. 3048-3053.
Fokas E., Wacker U., Gross M.W., et al. Hypofractionated stereotactic reirradiation of recurrent glioblastomas: A beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol. 2009. V. 185. P. 235-240.
Gutin P., Iwamoto F., Beal K., et al. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2009. V. 75. No. 1. P. 156-163.
Hochberg F.H., Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology. 1980. V. 30. P. 907-911.
Ito Y., Kimura Y., Shimahara T., et al. Disposition of TF-PEG-Liposome-BSH in tumor-bearing mice. Appl Radiat Isot. 2009. V. 67. (7-8 Suppl.). S109-S110.
Kankaanranta L., Seppälä T., Koivunoro H., et al. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial. Int J Radiat Oncol Biol Phys. 2012. V. 82. No. 1. P. e67-75.
Kato I., Ono K., Sakurai Y., et al. Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot. 2004. V. 61. No. 5. P. 1069-1073.
Kato I., Fujita Y., Maruhashi A., et al. Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies. Appl Radiat Isot. 2009. V. 67. (7-8 Suppl). P. S37-S42.
Kondziolka D., Lunsford L., Flickinger J. The radiobiology of radiosurgery. Neurosurg Clin North Am. 1999. V. 10. No. 2. P. 157-166.
Langleben D.D., Segall G.M. PET in differentiation of recurrent brain tumor from radiation injury. J Nucl. Med. 2000. V. 41. No. 11. P. 1861-1867.
Lederman G., Wronski M., Arbit E., et al. Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am. J Clin. Oncol. 2000. V. 23. No. 2. P. 155-159.
Leibel S.A., Sheline G.E. Tolerance of the brain and spinal cord to conventional irradiation. In: Gutin P., Leibel S., Sheline G. (eds). Radiation injury to the nervous system. New York. Raven Press. 1991. P. 239-256.
Levin V.A., Bidaut L., Hou P., et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011. V. 79. No. 5. P. 1487-1495. brain. Arch Pathol Lab Med. 1976. V. 100. N. 10. P. 531-534
Maranzano E., Anselmo P., Casale M., et al. Treatment of recurrent glioblastoma with stereotactic radiotherapy: Long-term results of a mono-institutional trial. Tumori. 2011. V. 97. No. 1. P. 56-61.
Mathews V., Barker P., Blackband S., et al. Cerebral metabolites in patients with acute and subacute strokes: concentrations determined by quantitative proton MR spectroscopy. AJR. Am J Roentgenol. 1995. V.165. No. 3. P. 633-638.
Mayer R., Sminia P. Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys. 2008. V. 70. No. 5. P. 1350-1360.
Miyashita M., Miyatake S., Imahori Y., et al. Evaluation of fluoride-labeled boronophenylalanine-PET imaging for the study of radiation effects in patients with glioblastomas. J Neurooncol. 2008. V. 89. No. 2. P. 239-246.
Moss R.L., Aizawa O., Beynon D., et al. The requirements and development of neutron beams for neutron capture therapy of brain cancer. J Neurooncol 1997. V. 33. No. 1-2. P. 27-
Nakamura H. Liposomal Boron Delivery for Neutron Capture Therapy. Methods in Enzymology. 2009. P.179-208.
Hatanaka H. Experience of boron neutron capture therapy for malignant brain tumours with special reference to the problems of postoperative CT follow-ups. Acta Neurochir Suppl. (Wien). 1988. V. 42. P. 187-192.
Hatanaka H. Clinical results of boron neutron capture therapy. Basic Life Sci. 1990. V.54.P. 15-21.
Nieder C., Andratschke N.H., Grosu A.L. Re-irradiation for Recurrent Primary Brain Tumors. Anticancer Res. 2016. V. 36. No. 10. P. 4985-4995.
Orlova A., Kononov L.O., Kimel B.G., et al. Conjugates of polyhedral boron compounds with carbohydrates. Hydrolytic stability of carborane-lactose conjugates depends on the structure of a spacer between the carborane cage and sugar moiety. Appl Organometal Chem. 2006. V. 20. P. 416-420.
Pan X., Wu G., Yang W., et al. Synthesis of cetuximab immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR. Bioconjug Chem. 2007. V. 18. No. 1. P. 101-108.
Mayer R., Sminia P. Reirradiation Tolerance of the Human Brain. Int J Radiat Oncol Biol Phys. 2008. V. 70. No. 5. P. 1350-1360.
Sheline G.E., Wara W.M., Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys. 1980. V. 6. P. 1215-1228.
Shepherd S.F., Laing R.W., Cosgrove V.P., et al. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys. 1997. V.37.No. 2. P. 393-398.
Sherriff J., Tamangani J., Senthil L., et al. Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide. Br J Radiol. 2013. V. 86. No. 1022: 20120414.
Sibrian-Vazquez M., Vicente M.G.H. Boron tumor-delivery for BNCT: Recent developments and perspectives.In Boron Science: New Technologies and Applications. Hosmane N.S. (Ed.); CRC Press. 2011. P. 209-232.
Sweet W.H. Practical problems in the past in the use of boron-slow neutron capture therapy in the treatment of glioblastoma multiforme. Proceedings of the First International Symposium on Neutron Capture Therapy. 1983. P. 376-378.
Torcuator R., Zuniga R., Mohan Y.S. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol. 2009. V. 94. No. 1. P. 63-68.
Traber F., Block W., Flacke S. 1H-MR Spectroscopy of brain tumors in the course of radiation therapy: use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence. Rofo. 2002. V. 174. No. 1. P. 33-42.
Lawrence Y.R., Li X.A., el Naqa I., et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys. 2010. V. 76 (3 Suppl.). P. S20-S27.
Wang L.W., Wang S.J., Chu PY., et al. BNCT for locally recurrent head and neck cancer: preliminary clinical experience from a phase I/II trial at Tsing Hua open-pool reactor. Appl Radiat Isot. 2011. V. 69. No. 12. P. 1803-1806.
Yang W., Barth R.F., Wu G., et al. Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4. Clin Cancer Res. 2006. V. 12. No. 12. P. 3792-3802.

Еще

Статья научная